Filtered By:
Source: Journal of Stroke and Cerebrovascular Diseases
Condition: Atrial Fibrillation
This page shows you your search results in order of date. This is page number 17.
Order by Relevance | Date
Total 320 results found since Jan 2013.
Characteristics of Sleep-Disordered Breathing in Etiologic Subtypes of Minor-to-Moderate Acute Ischemic Stroke
In this study, we evaluated the characteristics of SDB in etiologic subtypes of acute ischemic stroke. We also investigated the relationship between SDB and AF in acute ischemic stroke.
Source: Journal of Stroke and Cerebrovascular Diseases - March 20, 2015 Category: Neurology Authors: Pavel Šiarnik, Branislav Kollár, Zuzana Čarnická, Stanislav Šutovský, Katarína Klobučníková, Peter Turčáni Source Type: research
Embolic Stroke during Apixaban Therapy for Left Atrial Appendage Thrombus
Left atrial appendage (LAA) thrombus is associated with atrial fibrillation (AF) and is a powerful predictor of cardiogenic thromboembolism. Warfarin is an established anticoagulant therapy for patients with LAA thrombus to prevent thromboembolic complications. Apixaban is superior to warfarin in the prevention of thromboembolic complications in patients with AF, and there are case reports showing apixaban-associated resolution of LAA thrombus; however, the efficacy and safety of apixaban for the treatment of LAA thrombus remains unproven.
Source: Journal of Stroke and Cerebrovascular Diseases - January 22, 2015 Category: Neurology Authors: Masaki Ohyagi, Kazuha Nakamura, Mutsufusa Watanabe, Hiroto Fujigasaki Tags: Case Report Source Type: research
Intratumoral Hemorrhage in a Patient with Malignant Meningioma under Anticoagulant Therapy
We report the case of an elderly woman with malignant meningioma and atrial fibrillation who started taking anticoagulants after an ischemic stroke and subsequently developed intratumoral hemorrhage. Further studies are required to confirm whether a particular anticoagulant agent is suitable for patients with brain tumor and atrial fibrillation.
Source: Journal of Stroke and Cerebrovascular Diseases - January 22, 2015 Category: Neurology Authors: Yasuyuki Ito, Makoto Nakajima, Mari Watari, Tetsuro Sakamoto, Yoichiro Hashimoto, Seiji Tajiri, Akira Takada, Yukio Ando Tags: Case Report Source Type: research
Knowledge Regarding Oral Anticoagulation Therapy among Patients with Stroke and Those at High Risk of Thromboembolic Events
Apart from atrial fibrillation, indications for oral anticoagulation common in our clinical practice include rheumatic heart disease and mechanical heart valve replacement. Evaluation of current patient knowledge regarding oral anticoagulation therapy (OAT) is the first step in improving the quality of anticoagulation therapy and patient care. The aim of the present study was to assess the knowledge regarding OAT among patients with stroke and those at high risk of thromboembolic events in a tertiary care hospital in India.
Source: Journal of Stroke and Cerebrovascular Diseases - January 7, 2015 Category: Neurology Authors: Annu Alphonsa, Kamlesh K. Sharma, Gautam Sharma, Rohit Bhatia Source Type: research
Intravenous Thrombolysis for Acute Ischemic Stroke in a Patient Receiving Rivaroxaban
Rivaroxaban is an oral direct factor Xa inhibitor increasingly used in stroke prevention in nonvascular atrial fibrillation, primary prevention and treatment of venous thromboembolism, and secondary prevention in acute coronary syndromes.
Source: Journal of Stroke and Cerebrovascular Diseases - January 2, 2015 Category: Neurology Authors: Anne Landais, Caroline Ginoux Tags: Case Report Source Type: research
Association of Plasma Brain Natriuretic Peptide Levels in Acute Ischemic Stroke Subtypes and Outcome
Brain natriuretic peptide (BNP) is believed to be a diagnostic marker for cardiovascular diseases, including atrial fibrillation (AF). Recent studies have incriminated BNP as a marker of cardioembolic stroke. We aimed at investigating association of plasma BNP levels in acute ischemic stroke subtypes and their outcome in Indian patients.
Source: Journal of Stroke and Cerebrovascular Diseases - December 15, 2014 Category: Neurology Authors: Jaydip Ray Chaudhuri, Vijay Kumar Sharma, Kandadai Rukmini Mridula, Banda Balaraju, Venkata Chandra Sekher Srinivasarao Bandaru Source Type: research
Incidence, Mortality, and Risk Factors for Oral Anticoagulant–associated Intracranial Hemorrhage in Patients with Atrial Fibrillation
Warfarin, a vitamin K epoxide reductase inhibitor, is the oral anticoagulant most commonly used to reduce the risk of stroke in patients with atrial fibrillation (AF). Warfarin has proved to be efficacious for this purpose in multiple clinical trials. However, warfarin use is laborious and associated with an increased risk of intracranial hemorrhage (ICH). Various factors increase the risk of warfarin-related ICH, including older age, intensity of anticoagulation, hypertension, and history of cerebrovascular disease.
Source: Journal of Stroke and Cerebrovascular Diseases - October 29, 2014 Category: Neurology Authors: Rebbeca Grysiewicz, Philip B. Gorelick Tags: Review Article Source Type: research
Troponin-I Is a Predictor of a Delayed Diagnosis of Atrial Fibrillation in Acute Ischemic Stroke and Transient Ischemic Attack
Prolonged cardiac monitoring detects higher rates of atrial fibrillation (AF) in ischemic stroke and transient ischemic attack (TIA) but is costly and has practical implications. The use of admission troponin-I (TnI) level to identify patients at high risk of delayed AF detection was investigated.
Source: Journal of Stroke and Cerebrovascular Diseases - October 17, 2014 Category: Neurology Authors: Frank Ward, Rory McGovern, Paul E. Cotter Source Type: research
Adherence to Oral Anticoagulation in Secondary Stroke Prevention—The First Year of Direct Oral Anticoagulants
Patients with ischemic stroke caused by atrial fibrillation (AF) have a high risk of recurrence without adequate secondary prevention with oral anticoagulation (OAC). We investigated adherence to OAC in the first year after introduction of direct oral anticoagulants.
Source: Journal of Stroke and Cerebrovascular Diseases - October 16, 2014 Category: Neurology Authors: Roland Sauer, Eva-Maria Sauer, Tobias Bobinger, Christian Blinzler, Hagen B. Huttner, Stefan Schwab, Martin Köhrmann Source Type: research
Clinical Outcomes of Persistent and Paroxysmal Atrial Fibrillation in Patients with Stroke
We compared the clinical outcomes of persistent atrial fibrillation (PeAF) and paroxysmal atrial fibrillation (PAF) in patients with cardioembolic stroke caused by nonvalvular atrial fibrillation (NVAF) because the nature of the fibrillation can cause persistent cerebral infarction.
Source: Journal of Stroke and Cerebrovascular Diseases - October 4, 2014 Category: Neurology Authors: Ichiro Deguchi, Takuya Fukuoka, Takeshi Hayashi, Hajime Maruyama, Yoshihide Sehara, Yuji Kato, Yohsuke Horiuchi, Yuito Nagamine, Hiroyasu Sano, Norio Tanahashi Source Type: research
Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator in a Stroke Patient Treated with Rivaroxaban
As limited amounts of data are available regarding thrombolytic therapy for patients taking novel oral anticoagulants, thrombolytic therapy is not recommended in such cases. Here, we report an acute stroke patient taking rivaroxaban who received intravenous thrombolysis with recombinant tissue plasminogen activator (rt-PA). An 80-year-old man with a history of nonvalvular atrial fibrillation, who had been receiving 10 mg of rivaroxaban showed abrupt onset of aphasia and right hemiparesis. National Institutes of Health Stroke Scale score was 10.
Source: Journal of Stroke and Cerebrovascular Diseases - September 30, 2014 Category: Neurology Authors: Hideyuki Ishihara, Hiroaki Torii, Hirochika Imoto, Fumiaki Oka, Hirokazu Sadahiro, Michiyasu Suzuki Tags: Case Report Source Type: research
Present Profiles of Novel Anticoagulant Use in Japanese Patients with Atrial Fibrillation: Insights from the Rivaroxaban Postmarketing Surveillance Registry
The postmarketing surveillance registry evaluated the safety and efficacy of rivaroxaban in Japanese patients with atrial fibrillation (AF) treated with rivaroxaban.
Source: Journal of Stroke and Cerebrovascular Diseases - September 20, 2014 Category: Neurology Authors: Satoshi Ogawa, Takanori Ikeda, Takanari Kitazono, Jyoji Nakagawara, Kazuo Minematsu, Susumu Miyamoto, Yuji Murakawa, Kazuma Iekushi, Satoshi Yamanaka, Takashi Yamada, Lyo Inuyama, on behalf of the Rivaroxaban PostMarketing Surveillance Registry Investigat Source Type: research
The Second Elevation of Neuron-Specific Enolase Peak after Ischemic Stroke Is Associated with Hemorrhagic Transformation
Conclusions: Serial NSE analysis during the acute period of ischemic stroke is useful for monitoring hemorrhagic transformation and the blood-brain barrier disruption status.
Source: Journal of Stroke and Cerebrovascular Diseases - September 1, 2014 Category: Neurology Authors: Bum Joon Kim, Yeon-Jung Kim, Sung Ho Ahn, Na Young Kim, Dong-Wha Kang, Jong S. Kim, Sun U. Kwon Tags: Original Articles Source Type: research
Association of the ASCO Classification with the Executive Function Subscores of the Montreal Cognitive Assessment in Patients with Postischemic Stroke
Conclusions: These results suggest that the ASCO phenotypic classification of stroke is useful not only for assessing the etiology of ischemic stroke but also for predicting cognitive decline after ischemic stroke.
Source: Journal of Stroke and Cerebrovascular Diseases - August 29, 2014 Category: Neurology Authors: Kazuo Washida, Masafumi Ihara, Hisatsugu Tachibana, Kenji Sekiguchi, Hisatomo Kowa, Fumio Kanda, Tatsushi Toda Tags: Original Articles Source Type: research
Impact of Atrial Fibrillation and Inadequate Antithrombotic Management on Mortality in Acute Neurovascular Syndrome
Conclusions: Patients with AF have more severe stroke and higher mortality than stroke patients without AF. Adherence to the antithrombotic treatment guidelines for the prevention of AF-related cardioembolic strokes is suboptimal. Further studies are needed to evaluate the impact of current antithrombotic treatment guidelines on mortality.
Source: Journal of Stroke and Cerebrovascular Diseases - August 25, 2014 Category: Neurology Authors: Jukka T. Saarinen, Harri Rusanen, Niko Sillanpää, Heini Huhtala, Heikki Numminen, Irina Elovaara Tags: Original Articles Source Type: research
